Hiwase, Devendra K.

Magrolimab plus azacitidine vs physician’s choice for untreated TP53 -mutated acute myeloid leukemia: the ENHANCE-2 study

Zeidner, J. F., Sallman, D. A., Récher, C., Daver, N. G., Leung, A. Y. H., Hiwase, D. K., Subklewe, M., Pabst, T., Montesinos, P., Larson, R. A., et al. (2025) · Blood

Acute Myeloid Leukemia ResearchRetinoids in leukemia and cellular processes

Cited by 76

Loss of caspase-2 augments lymphomagenesis and enhances genomic instability in Atm -deficient mice

Puccini, J., Shalini, S., Voss, A. K., Gatei, M., Wilson, C. H., Hiwase, D. K., Lavin, M. F., Dorstyn, L., & Kumar, S. (2013) · Proceedings of the National Academy of Sciences

Cell death mechanisms and regulationDNA Repair Mechanisms

Cited by 69

The mutational burden of therapy-related myeloid neoplasms is similar to primary myelodysplastic syndrome but has a distinctive distribution

Singhal, D., Wee, L. Y. A., Kutyna, M. M., Chhetri, R., Geoghegan, J., Schreiber, A. W., Feng, J., Wang, P. P.-S., Babic, M., Parker, W. T., et al. (2019) · Leukemia

Acute Myeloid Leukemia ResearchMultiple and Secondary Primary Cancers

Cited by 62

Impaired haematopoietic stem cell differentiation and enhanced skewing towards myeloid progenitors in aged caspase-2-deficient mice

Dawar, S., Shahrin, N. H., Sladojevic, N., D'Andrea, R. J., Dorstyn, L., Hiwase, D. K., & Kumar, S. (2016) · Cell Death & Disease

Hematopoietic Stem Cell TransplantationCell death mechanisms and regulation

Cited by 30

Evidence-based risk stratification of myeloid neoplasms harboring TP53 mutations

Shah, M. V., Hung, K., Baranwal, A., Kutyna, M. M., Al-Kali, A., Toop, C., Greipp, P., Brown, A., Shah, S., Khanna, S., et al. (2025) · Blood Advances

Acute Myeloid Leukemia ResearchChronic Myeloid Leukemia Treatments

Cited by 23